Ibriturnomab tiuxetan (Zevalin) in the conditioning regimen for autologous and reduced-intensity allogeneic stem-cell transplantation in patients with chemo-refractory non-Hodgkin's lymphoma.

被引：0

作者：

Shimoni, A ^{[1
]}

Zwas, T ^{[1
]}

Oksman, Y ^{[1
]}

Hardan, I ^{[1
]}

Shem-Tov, N ^{[1
]}

Yerushalmi, R ^{[1
]}

Avigdor, A ^{[1
]}

Ben-Bassat, I ^{[1
]}

Nagler, A ^{[1
]}

机构：

[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel

来源：

BLOOD | 2005年 / 106卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1131

引用

页码：329A / 329A

页数：1

共 50 条

[21] Ibritumomab tiuxetan (Zevalin) followed by high-dose chemotherapy and autologous stem-cell transplantation results in improved survival of patients with chemo-refractory non-Hodgkin's lymphoma expected to have poor outcome with standard pre-transplant conditioning. [J].

Shimoni, Avichai ;

Zwass, Tsila ;

Oksman, Yaacov ;

Hardan, Izhar ;

Shem-Tov, Noga ;

Yerushalmi, Ronit ;

Avigdor, Abraham ;

Ben-Bassat, Isaac ;

Nagler, Arnon .

BLOOD, 2006, 108 (11) :869A-869A

[22] Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome [J].

Armand, Philippe ;

Kim, Haesook T. ;

Ho, Vincent T. ;

Cutler, Corey S. ;

Koreth, John ;

Antin, Joseph H. ;

LaCasce, Ann S. ;

Jacobsen, Eric D. ;

Fisher, David C. ;

Brown, Jennifer R. ;

Canellos, George P. ;

Freedman, Arnold S. ;

Soiffer, Rohert J. ;

Alyea, Edwin P. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (04) :418-425

[23] Conditioning Regimen Comparison for Allogeneic Stem Cell Transplantation in non-hodgkin Lymphoma [J].

Peterson, Kristen ;

Lin, Andrew ;

Ruiz, Josel ;

Zheng, Junting ;

Devlin, Sean ;

Shah, Gunjan ;

Scordo, Michael ;

Sauter, Craig ;

Perales, Miguel ;

Giralt, Sergio ;

Buie, Larry ;

Dahi, Parastoo .

BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) :299-300

[24] Autologous stem-cell transplantation in Hodgkin's and non-Hodgkin's lymphoma [J].

Greinix, HT .

ACTA MEDICA AUSTRIACA, 2000, 27 :25-29

[25] Reduced-intensity rituximab-BEAM-CAMPATH allogeneic transplantation for indolent non-Hodgkin's lymphoma. [J].

Ho, AYL ;

Devereux, S ;

Mufti, GL ;

Pagliuca, A .

BLOOD, 2001, 98 (11) :188A-188A

[26] Autologous stem cell transplantation in patients with refractory and/or relapsed low grade non-Hodgkin's lymphoma. [J].

Mallidi, PV ;

Qazilbash, MH ;

Devetten, MP ;

Beall, CL ;

Weisenborn, R ;

Bunner, P ;

Ericson, SG .

BLOOD, 2001, 98 (11) :394B-394B

[27] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma [J].

Anderlini, Paolo ;

Saliba, Rima M. ;

Ledesma, Celina ;

Plair, Tamera ;

Alousi, Amin M. ;

Hosing, Chitra M. ;

Khouri, Issa F. ;

Nieto, Yago ;

Popat, Uday R. ;

Shpall, Elizabeth J. ;

Fanale, Michelle A. ;

Hagemeister, Frederick B. ;

Oki, Yasuhiro ;

Neelapu, Saatva ;

Romaguera, Jorge E. ;

Younes, Anas ;

Champlin, Richard E. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) :1333-1337

[28] Allogeneic peripheral blood stem cell transplantation after reduced-intensity conditioning in refractory or relapsed Hodgkin lymphoma [J].

Alvarez, I ;

Sureda, A ;

Caballero, D ;

Urbano, A ;

Ribera, J ;

Canales, M ;

Hernández-Boluda, J ;

Arranz, R ;

Bernal, T ;

de la Serna, J ;

Diez, JL ;

Moraleda, J ;

Rubio-Félix, D ;

Sierra, J .

BONE MARROW TRANSPLANTATION, 2004, 33 :S13-S14

[29] Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin Era [J].

Anderlini, Paolo ;

Saliba, Rima ;

Ledesma, Celina ;

Chancoco, Christina M. ;

Alexander, Tamera R. ;

Alousi, Amin M. ;

Hosing, Chitra ;

Khouri, Issa F. ;

Nieto, Yago ;

Popat, Uday R. ;

Shpall, Elizabeth J. ;

Fanale, Michelle A. ;

Oki, Yasuhiro ;

Romaguera, Jorge E. ;

Neelapu, Sattva S. ;

Younes, Anas ;

Champlin, Richard E. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) :S72-S72

[30] Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic haematopoietic cell transplantation in patients with advanced low/intermediate grade non-Hodgkin lymphoma [J].

Bethge, W. A. ;

Bornhaeuser, M. ;

Lange, T. ;

Vucinic, V. ;

Uharek, L. ;

Stelljes, M. ;

Stadler, M. ;

Bunjes, D. ;

Faul, C. ;

Kanz, L. .

BONE MARROW TRANSPLANTATION, 2007, 39 :S90-S90

← 1 2 3 4 5 →